Posts

Abu Dhabi Stem Cells Center develops clinical-grade iPSCs

The Abu Dhabi Stem Cells Center (ADSCC) has developed clinical-grade induced plu...

China’s NMPA approves GSK’s Nucala for CRSwNP treatment

The China NMPA has approved GSK’s Nucala (mepolizumab) as an add-on treatment al...

BNT-325 by BioNTech for Malignant Mesothelioma: Likelih...

BNT-325 is under clinical development by BioNTech and currently in Phase II for ...

Age Matters: Enhanced Precision in Kidney Disorder Dete...

Annual health check-ups typically involve routine urine tests, which play a vita...

Extended Paxlovid Treatment Shows Promise for Alleviati...

A near-scrutinizing examination of how patients respond to Paxlovid, particularl...

Neumora shares sink following Phase III flop in MDD

The Phase III KOASTAL-1 study with Neumora’s lead asset navacaprant failed to me...

Leading strategic intelligence solutions for the pharma...

Explore how strategic intelligence agencies and competitive intelligence solutio...

UK MHRA approves MSD’s pulmonary arterial hypertension ...

MSD has received the UK MHRA approval for sotatercept, marketed as Winrevair, to...

Tirzepatide outpacing Wegovy in the obesity space

Eli Lilly and Novo Nordisk have been competing in the obesity market for the pas...

The unmet need in T2-low asthma: A critical gap in trea...

Severe asthma is traditionally classified into either high or low T-helper cell ...

Expanding diagnostic and biomarker options to improve M...

Distinguishing the stages of fibrosis in MASH is a pressing need for diagnoses a...

IIT Guwahati and Bose Institute develop injectable hydr...

The Indian Institute of Technology (IIT) Guwahati and the Bose Institute Kolkata...

From Davids to Goliaths: the GLP-1RA gold rush

There are now more than 300 GLP-1Rs in an active stage of development, from indu...

SIGA’s antiviral approved in Japan for orthopoxvirus tr...

SIGA Technologies has gained the Japanese regulatory approval for TEPOXX (tecovi...

China’s NMPA prioritises HUTCHMED’s lung cancer therapy...

China NMPA has granted acceptance and priority review for the NDA for HUTCHMED’s...

AI-Powered Solutions: Enhancing Suicide Risk Identifica...

A groundbreaking study conducted by a team at Vanderbilt University Medical Cent...